Ironwood Pharmaceuticals | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Almirall EUR 91.3M 55.52M 2025-03
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amarin USD 36.57M 397K 2025-03
Ardelyx USD 76.07M 11.1M 2024-12
Astellas Pharma JPY 197B 14.32B 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Charles River Laboratories USD 185.82M 8.02M 2025-06
Exact Sciences USD 455.7M 29.3M 2025-06
Halozyme Therapeutics USD 33M 9.36M 2025-06
Incyte USD 331.02M 5.33M 2025-06
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 230M 18M 2025-06
Myriad Genetics USD 135.7M 300K 2025-03
Pacira USD 77.19M 9.58M 2025-06
PTC Therapeutics USD 85.26M 76.66M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Takeda JPY 255.89B 39.98B 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06


Ironwood Pharmaceuticals Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.